AI Verdict
HROW has stronger fundamentals based on our AI analysis.
HRTX vs HROW Fundamental Comparison
| Metric | HRTX | HROW |
|---|---|---|
| Revenue | $154.9M | $272.3M |
| Net Income | $-20.2M | $-5.1M |
| Net Margin | -13.0% | -1.9% |
| ROE | -140.9% | -9.8% |
| ROA | -7.9% | -1.3% |
| Current Ratio | 2.48x | 2.20x |
| Debt/Equity | 0.00x | 4.77x |
| EPS | $-0.12 | $-0.14 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HRTX vs HROW: Frequently Asked Questions
Is HRTX or HROW a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HROW has stronger fundamentals. HRTX is rated STRONG SELL (87% confidence) while HROW is rated HOLD (68% confidence). This is not investment advice.
How does HRTX compare to HROW fundamentally?
HERON THERAPEUTICS, INC. /DE/ has ROE of -140.9% vs HARROW, INC.'s -9.8%. Net margins are -13.0% vs -1.9% respectively.
Which stock pays higher dividends, HRTX or HROW?
HRTX has a dividend yield of N/A or no dividend while HROW has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HRTX or HROW for long term?
For long-term investing, consider that HRTX has STRONG SELL rating with 87% confidence, while HROW has HOLD rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HRTX vs HROW?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HRTX vs HROW, the AI consensus favors HROW based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.